In addition, it addresses the FDA’s communications with the applicant, the retention of documents that assistance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer possession of the SE report back to a brand new applicant and Digital submission in the SE repo